You are here: Home: LCU Think Tank 1 | 2006: Section 4: Select publications

SELECT PUBLICATIONS

Birim O et al. Survival after pathological stage IA nonsmall cell lung cancer: Tumor size matters. Ann Thorac Surg 2005;79(4):1137-41. Abstract

Douillard JY et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): A randomised controlled trial. Lancet Oncol 2006;7(9):719-27. Abstract

Dunant A et al. Adjuvant chemotherapy for non-small cell lung cancer: Contribution of the International Adjuvant Lung Trial. Clin Cancer Res 2005;11(13 Pt 2):5017-21. Abstract

Fossella F et al. Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: The TAX 326 study group. J Clin Oncol 2003;21(16):3016-24. Abstract

Jones DR et al. Stage IB nonsmall cell lung cancers: Are they all the same? Ann Thorac Surg 2006;81(6):1958-62. Abstract

Kawai H et al; The Japan National Hospital Study Group for Lung Cancer. Smoking history before surgery and prognosis in patients with stage IA non-small-cell lung cancer — A multicenter study. Lung Cancer 2005;49(1):63-70. Abstract

Kudoh S et al. Phase III study of docetaxel compared with vinorelbine in elderly patients with advanced non-small-cell lung cancer: Results of the West Japan Thoracic Oncology Group Trial (WJTOG 9904). J Clin Oncol 2006;24(22):3657-63. Abstract

Paccagnella A et al. Adding gemcitabine to paclitaxel/carboplatin combination increases survival in advanced non-small-cell lung cancer: Results of a phase II-III study. J Clin Oncol 2006;24(4):681-7. Abstract

Potti A, Ganti AK. Adjuvant chemotherapy for early-stage non-small cell lung cancer: The past, the present and the future. Expert Opin Biol Ther 2006;6(7):709-16. Abstract

Ramlau R et al. Phase III study comparing oral topotecan to intravenous docetaxel in patients with pretreated advanced non-small-cell lung cancer. J Clin Oncol 2006;24(18):2800-7. Abstract

Roselli M et al. Postsurgical chemotherapy in stage IB nonsmall cell lung cancer: Longterm survival in a randomized study. Int J Cancer 2006;119(4):955-60. Abstract

Schuette W et al. Phase III study of second-line chemotherapy for advanced non-small-cell lung cancer with weekly compared with 3-weekly docetaxel. J Clin Oncol 2005;23(33):8389-95. Abstract

Strauss GM et al. Adjuvant chemotherapy in stage IB non-small cell lung cancer (NSCLC): Update of Cancer and Leukemia Group B (CALGB) protocol 9633. Presentation. Proc ASCO 2006;Abstract 7007.

Visbal AL et al. Adjuvant chemotherapy for early-stage non-small cell lung cancer. Chest 2005;128(4):2933-43. Abstract

Wakelee HA et al. Current status of adjuvant chemotherapy for stage IB non-small-cell lung cancer: Implications for the New Intergroup Trial. Clin Lung Cancer 2006;8(1):18-21. Abstract

Winton T et al; National Cancer Institute of Canada Clinical Trials Group; National Cancer Institute of the United States Intergroup JBR.10 Trial Investigators. Vinorelbine plus cisplatin vs observation in resected non-small-cell lung cancer. N Engl J Med 2005;352(25):2589-97. Abstract

Yamamoto N et al. Randomized phase II study of carboplatin/gemcitabine versus vinorelbine /gemcitabine in patients with advanced nonsmall cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) 0104. Cancer 2006;107(3):599-605. Abstract

Table of Contents

Top of Page